Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK.

Mace PD, Wallez Y, Egger MF, Dobaczewska MK, Robinson H, Pasquale EB, Riedl SJ.

Nat Commun. 2013;4:1681. doi: 10.1038/ncomms2687.

2.

Quantifying ERK2-protein interactions by fluorescence anisotropy: PEA-15 inhibits ERK2 by blocking the binding of DEJL domains.

Callaway K, Rainey MA, Dalby KN.

Biochim Biophys Acta. 2005 Dec 30;1754(1-2):316-23. Epub 2005 Nov 16. Review.

PMID:
16324895
3.

Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.

Greig FH, Nixon GF.

Pharmacol Ther. 2014 Sep;143(3):265-74. doi: 10.1016/j.pharmthera.2014.03.006. Epub 2014 Mar 20. Review.

4.

Dimerization in MAP-kinase signaling.

Cobb MH, Goldsmith EJ.

Trends Biochem Sci. 2000 Jan;25(1):7-9. Review.

PMID:
10637602
5.
6.

On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities.

Wei Y.

Pharmaceuticals (Basel). 2015 Jul 31;8(3):455-73. doi: 10.3390/ph8030455. Review.

Supplemental Content

Support Center